Getinge Interim Report January-September 2016
Third quarter of 2016 in brief · Order intake decreased 3.0% to SEK 7,176 M (7,397). The order intake declined organically by 3.2%. · Net sales increased 0.1% to SEK 6,929 M (6,925). Net sales increased organically by 0.2%. · Gross margin increased to 47.3% (46.8). · EBITA* improved 16.3% to SEK 963 M (828). · Restructuring costs increased to SEK 732 M (213). SEK 628 M comprises a provision for the FDA-related remediation program, write-down of an R&D project and costs for changes among senior executives. · Profit before tax decreased 146.2% to SEK -110 M (238), due to